Adiponectin Relationship with Lipid Metabolism Is Independent of Body Fat Mass: Evidence from Both Cross-Sectional and Intervention Studies
Roberto Baratta,
Sabrina Amato,
Claudia Degano,
Maria Grazia Farina,
Giovanni Patanè,
Riccardo Vigneri and
Lucia Frittitta
Division of Endocrinology, Department of Internal and Specialistic Medicine, Garibaldi Hospital, University of Catania Medical School, 95123 Catania, Italy
Address all correspondence and requests for reprints to: Lucia Frittitta, M.D., Endocrinologia, Ospedale Garibaldi, Piazza S. M. di Gesù, 95123 Catania, Italy. E-mail: lfritti{at}unict.it.
Adiponectin influences insulin sensitivity and lipid metabolism,but it is not clear whether these effects are correlated withfat mass or distribution. We studied the relationship betweenplasma adiponectin and leptin levels, insulin sensitivity, andserum lipids by a cross-sectional study (n = 242 subjects) andby an intervention study (95 of 242) to evaluate the effectof weight loss (WL).
Considering all subjects both together and subdivided into nonobese(n = 107) and obese (n = 135) groups, plasma adiponectin, butnot plasma leptin, was significantly (P < 0.01) correlatedwith insulin sensitivity [homeostasis model assessment of insulin-resistanceindex (HOMAIR), insulin sensitivity index (ISI) at oral glucosetolerance test, and clamp in 115 of 242 individuals], high-densitylipoprotein cholesterol, and triglycerides. These relationshipswere still significant (P < 0.01) after adjusting for age,gender, body mass index (BMI), and ISI. After WL (16.8± 0.8%), plasma adiponectin increased, and plasma leptindecreased (P < 0.0001 for both). Their changes () were significantlycorrelated with -BMI (P < 0.05 for both). -Adiponectin, butnot -leptin, significantly (P < 0.001) correlated with -high-densitylipoprotein cholesterol and -triglycerides; these correlationswere independent of age, gender, -BMI, and -ISI (P < 0.005).In conclusion, both cross-sectional and intervention studiesindicate that plasma adiponectin level correlates with serumlipids independently of fat mass. The intervention study alsosuggests that adiponectin increase after WL is correlated withserum lipid improvement independently of insulin sensitivitychanges.
This work was supported by the Ministero Italiano della Salute,Ricerca Finalizzata 2001, Obesity and Insulin Resistance, andby the University of Catania, Ricerca Ateneo 2002 (both to L.F.).
Abbreviations: BMI, Body mass index; HDL-C, high-density lipoprotein-cholesterol;HOMAIR, homeostasis model assessment of insulin-resistance index;ISI, insulin sensitivity index; OGTT, oral glucose tolerancetest; WHR, waist-to-hip ratio; WL, weight loss.
This article has been cited by other articles:
R. Weiss and J. D. Kark Adiponectin and Lipoprotein Particle Size: Response to Tsuzaki et al.
Diabetes Care,
January 1, 2010;
33(1):
e12 - e12.
[Full Text][PDF]
D. C. Chan, P. H. R. Barrett, E. M. M. Ooi, J. Ji, D. T. Chan, and G. F. Watts Very Low Density Lipoprotein Metabolism and Plasma Adiponectin as Predictors of High-Density Lipoprotein Apolipoprotein A-I Kinetics in Obese and Nonobese Men
J. Clin. Endocrinol. Metab.,
March 1, 2009;
94(3):
989 - 997.
[Abstract][Full Text][PDF]
A. Cassidy, P. Skidmore, E. B. Rimm, A. Welch, S. Fairweather-Tait, J. Skinner, K. Burling, J. B. Richards, T. D. Spector, and A. J. MacGregor Plasma Adiponectin Concentrations Are Associated with Body Composition and Plant-Based Dietary Factors in Female Twins
J. Nutr.,
February 1, 2009;
139(2):
353 - 358.
[Abstract][Full Text][PDF]
L. Qiao, C. Zou, D. R. van der Westhuyzen, and J. Shao Adiponectin Reduces Plasma Triglyceride by Increasing VLDL Triglyceride Catabolism
Diabetes,
July 1, 2008;
57(7):
1824 - 1833.
[Abstract][Full Text][PDF]
T. Tanaka, T. Tsutamoto, H. Sakai, K. Nishiyama, M. Fujii, T. Yamamoto, and M. Horie Effect of atrial natriuretic peptide on adiponectin in patients with heart failure
Eur J Heart Fail,
April 1, 2008;
10(4):
360 - 366.
[Abstract][Full Text][PDF]
S. E. Yeo, N. P. Hays, R. A. Dennis, P. M. Kortebein, D. H. Sullivan, W. J. Evans, and R. H. Coker Fat Distribution and Glucose Metabolism in Older, Obese Men and Women
J Gerontol A Biol Sci Med Sci,
December 1, 2007;
62(12):
1393 - 1401.
[Abstract][Full Text][PDF]
M. A. Sabin, M. De Hora, J. M.P. Holly, L. P. Hunt, A. L. Ford, S. R. Williams, J. S. Baker, C. J. Retallick, E. C. Crowne, and J. P.H. Shield Fasting Nonesterified Fatty Acid Profiles in Childhood and Their Relationship With Adiposity, Insulin Sensitivity, and Lipid Levels
Pediatrics,
December 1, 2007;
120(6):
e1426 - e1433.
[Abstract][Full Text][PDF]
A. Galler, G. Gelbrich, J. Kratzsch, N. Noack, T. Kapellen, and W. Kiess Elevated serum levels of adiponectin in children, adolescents and young adults with type 1 diabetes and the impact of age, gender, body mass index and metabolic control: a longitudinal study
Eur. J. Endocrinol.,
October 1, 2007;
157(4):
481 - 489.
[Abstract][Full Text][PDF]
N. Matikainen, S. Manttari, J. Westerbacka, S. Vehkavaara, N. Lundbom, H. Yki-Jarvinen, and M.-R. Taskinen Postprandial Lipemia Associates with Liver Fat Content
J. Clin. Endocrinol. Metab.,
August 1, 2007;
92(8):
3052 - 3059.
[Abstract][Full Text][PDF]
T. Sir-Petermann, B. Echiburu, M M. Maliqueo, N. Crisosto, F. Sanchez, C. Hitschfeld, M. Carcamo, P. Amigo, and F. Perez-Bravo Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome
Hum. Reprod.,
July 1, 2007;
22(7):
1830 - 1836.
[Abstract][Full Text][PDF]
S. Santosa, I. Demonty, A. H. Lichtenstein, K. Cianflone, and P. J.H. Jones An Investigation of Hormone and Lipid Associations after Weight Loss in Women
J. Am. Coll. Nutr.,
June 1, 2007;
26(3):
250 - 258.
[Abstract][Full Text][PDF]
E. Lin, L. S. Phillips, T. R. Ziegler, B. Schmotzer, K. Wu, L. H. Gu, L. Khaitan, S. A. Lynch, W. E. Torres, C. D. Smith, et al. Increases in Adiponectin Predict Improved Liver, but Not Peripheral, Insulin Sensitivity in Severely Obese Women During Weight Loss
Diabetes,
March 1, 2007;
56(3):
735 - 742.
[Abstract][Full Text][PDF]
G. Sun, J. Bishop, S. Khalili, S. Vasdev, V. Gill, D. Pace, D. Fitzpatrick, E. Randell, Y.-G. Xie, and H. Zhang Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men
Am. J. Clinical Nutrition,
February 1, 2007;
85(2):
399 - 404.
[Abstract][Full Text][PDF]
M. E. Trujillo and P. E. Scherer Adipose Tissue-Derived Factors: Impact on Health and Disease
Endocr. Rev.,
December 1, 2006;
27(7):
762 - 778.
[Abstract][Full Text][PDF]
F. Abbasi, H. M. F. Farin, C. Lamendola, T. McLaughlin, E. A. Schwartz, G. M. Reaven, and P. D. Reaven The Relationship between Plasma Adiponectin Concentration and Insulin Resistance Is Altered in Smokers
J. Clin. Endocrinol. Metab.,
December 1, 2006;
91(12):
5002 - 5007.
[Abstract][Full Text][PDF]
K. Kantartzis, K. Rittig, B. Balletshofer, J. Machann, F. Schick, K. Porubska, A. Fritsche, H.-U. Haring, and N. Stefan The Relationships of Plasma Adiponectin with a Favorable Lipid Profile, Decreased Inflammation, and Less Ectopic Fat Accumulation Depend on Adiposity
Clin. Chem.,
October 1, 2006;
52(10):
1934 - 1942.
[Abstract][Full Text][PDF]
M.-H. Gannage-Yared, S. Khalife, M. Semaan, F. Fares, S. Jambart, and G. Halaby Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men.
Eur. J. Endocrinol.,
July 1, 2006;
155(1):
167 - 176.
[Abstract][Full Text][PDF]
N. Bansal, V. Charlton-Menys, P. Pemberton, P. McElduff, J. Oldroyd, A. Vyas, A. Koudsi, P. E. Clayton, J. K. Cruickshank, and P. N. Durrington Adiponectin in Umbilical Cord Blood Is Inversely Related to Low-Density Lipoprotein Cholesterol But Not Ethnicity
J. Clin. Endocrinol. Metab.,
June 1, 2006;
91(6):
2244 - 2249.
[Abstract][Full Text][PDF]
B. Verges, J. M. Petit, L. Duvillard, G. Dautin, E. Florentin, F. Galland, and P. Gambert Adiponectin Is an Important Determinant of ApoA-I Catabolism
Arterioscler Thromb Vasc Biol,
June 1, 2006;
26(6):
1364 - 1369.
[Abstract][Full Text][PDF]
B. Buemann, A. Astrup, O. Pedersen, E. Black, C. Holst, S. Toubro, S. Echwald, J. J. Holst, C. Rasmussen, and T. I. A. Sorensen Possible Role of Adiponectin and Insulin Sensitivity in Mediating the Favorable Effects of Lower Body Fat Mass on Blood Lipids
J. Clin. Endocrinol. Metab.,
May 1, 2006;
91(5):
1698 - 1704.
[Abstract][Full Text][PDF]
M. von Eynatten, A. Hamann, D. Twardella, P. P. Nawroth, H. Brenner, and D. Rothenbacher Relationship of Adiponectin with Markers of Systemic Inflammation, Atherogenic Dyslipidemia, and Heart Failure in Patients with Coronary Heart Disease
Clin. Chem.,
May 1, 2006;
52(5):
853 - 859.
[Abstract][Full Text][PDF]
M. Sumiyoshi, M. Sakanaka, and Y. Kimura Chronic Intake of High-Fat and High-Sucrose Diets Differentially Affects Glucose Intolerance in Mice
J. Nutr.,
March 1, 2006;
136(3):
582 - 587.
[Abstract][Full Text][PDF]
E. Kishino, T. Ito, K. Fujita, and Y. Kiuchi A Mixture of the Salacia reticulata (Kotala himbutu) Aqueous Extract and Cyclodextrin Reduces the Accumulation of Visceral Fat Mass in Mice and Rats with High-Fat Diet-Induced Obesity
J. Nutr.,
February 1, 2006;
136(2):
433 - 439.
[Abstract][Full Text][PDF]
G. M. van der Vleuten, L. J. H. van Tits, M. den Heijer, H. Lemmers, A. F. H. Stalenhoef, and J. de Graaf Decreased adiponectin levels in familial combined hyperlipidemia patients contribute to the atherogenic lipid profile
J. Lipid Res.,
November 1, 2005;
46(11):
2398 - 2404.
[Abstract][Full Text][PDF]
T. Bobbert, H. Rochlitz, U. Wegewitz, S. Akpulat, K. Mai, M. O. Weickert, M. Mohlig, A. F.H. Pfeiffer, and J. Spranger Changes of Adiponectin Oligomer Composition by Moderate Weight Reduction
Diabetes,
September 1, 2005;
54(9):
2712 - 2719.
[Abstract][Full Text][PDF]
D. Rothenbacher, H. Brenner, W. Marz, and W. Koenig Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers
Eur. Heart J.,
August 2, 2005;
26(16):
1640 - 1646.
[Abstract][Full Text][PDF]
S. Pilz, R. Horejsi, R. Moller, G. Almer, H. Scharnagl, T. Stojakovic, R. Dimitrova, G. Weihrauch, M. Borkenstein, W. Maerz, et al. Early Atherosclerosis in Obese Juveniles Is Associated with Low Serum Levels of Adiponectin
J. Clin. Endocrinol. Metab.,
August 1, 2005;
90(8):
4792 - 4796.
[Abstract][Full Text][PDF]
J. B Ruige, D. P Ballaux, T. Funahashi, I. L Mertens, Y. Matsuzawa, and L. F Van Gaal Resting metabolic rate is an important predictor of serum adiponectin concentrations: potential implications for obesity-related disorders
Am. J. Clinical Nutrition,
July 1, 2005;
82(1):
21 - 25.
[Abstract][Full Text][PDF]
E. Bugianesi, U. Pagotto, R. Manini, E. Vanni, A. Gastaldelli, R. de Iasio, E. Gentilcore, S. Natale, M. Cassader, M. Rizzetto, et al. Plasma Adiponectin in Nonalcoholic Fatty Liver Is Related to Hepatic Insulin Resistance and Hepatic Fat Content, Not to Liver Disease Severity
J. Clin. Endocrinol. Metab.,
June 1, 2005;
90(6):
3498 - 3504.
[Abstract][Full Text][PDF]
T. W.K. Ng, G. F. Watts, M. S. Farvid, D. C. Chan, and P. H. R. Barrett Adipocytokines and VLDL Metabolism: Independent Regulatory Effects of Adiponectin, Insulin Resistance, and Fat Compartments on VLDL Apolipoprotein B-100 Kinetics?
Diabetes,
March 1, 2005;
54(3):
795 - 802.
[Abstract][Full Text][PDF]
D. C. Chan, G. F. Watts, T. W.K. Ng, Y. Uchida, N. Sakai, S. Yamashita, and P. H. R. Barrett Adiponectin and other Adipocytokines as Predictors of Markers of Triglyceride-Rich Lipoprotein Metabolism
Clin. Chem.,
March 1, 2005;
51(3):
578 - 585.
[Abstract][Full Text][PDF]